Pittsburgh scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19.
At 3 Rivers Venture Fair, panel discussion, CEOs address what happened when they changed direction due to Covid-19.
This organization is on a mission to improve virtual care and mobile engagements for seniors.
Cerevance, a private drug discovery and development company focused on brain diseases, recently announced positive results from a Phase 1b clinical trial.
Texas Children’s Hospital adopts purchasing management platform to reduce costs, improve supply chain efficiencies.
Data released by CMS last month show that Medicare Advantage health plans partnering with analytics and clinical services company RxAnte continue to outpace industry performance.
SparingVision (the “Company”), a genomic medicine company focused on ocular diseases, today announces the strengthening of its senior management team with the appointment of Dr. Florence Lorget as Chief Development Sciences Officer (“CDSO”) and Dr. Rajiv Gangurde as Chief Technology Officer (“CTO”).
Expansion of leadership team with deep translational oncology drug development expertise as Company prepares for clinical development of lead programs
